Final infarct volume estimation on 1-week follow-up MR imaging is feasible and is dependent on recanalization status

NeuroImage: Clinical

Volumn 7, Issue 1, 2015, Pages 1-6

  Krongold, Mark ^a,b,c   Almekhlafi, Mohammed A ^a,b,d   Demchuk, Andrew M ^a,b   Coutts, Shelagh B ^a,b,c   Frayne, Richard ^a,b,c   Eilaghi, Armin ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Infarct volume; Ischemic stroke; MRI; Recanalization; Sub acute

Indexed keywords

AGED; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; FEMALE; FOLLOW UP; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECANALIZATION; FEASIBILITY STUDY; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; STROKE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84910606021     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2014.10.010     Document Type: Article

References (30)

1. MR Stroke Collaborative Group Phan T.G., Donnan G.A., Davis S.M., and Byrnes G. Proof-of-principle phase II MRI studies in stroke: sample size estimates from dichotomous and continuous data Stroke 37 2006 2521 2525 10.1161/01.STR.0000239696.61545.4b 16931782
2. Anon The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. TIMI study group N. Engl. J. Med. 312 14 1985 932 936 10.1056/NEJM198504043121435 4038784
3. Coutts S.B., Eliasziw M., Hill M.D., Scott J.N., Subramaniam S., Buchan A.M., and et al. An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke Int J Stroke 3 1 2008 3 10 10.1111/j.1747-4949.2008.00182.x 18705908
4. Coutts S.B., Hill M.D., Eliasziw M., Fischer K., Demchuk A.M. VISION study group Final 2 year results of the vascular imaging of acute stroke for identifying predictors of clinical outcome and recurrent ischemic eveNts (VISION) study BMC Cardiovasc. Disord. 11 2011 18 10.1186/1471-2261-11-18 21513559
5. Coutts S.B., Lev M.H., Eliasziw M., Roccatagliata L., Hill M.D., Schwamm L.H., and et al. ASPECTS on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome Stroke 35 11 2004 2472 2476 10.1161/01.STR.0000145330.14928.2a 15486327
6. Davis S.M., Donnan G.A., Parsons M.W., Levi C., Butcher K.S., Peeters A., and et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial Lancet Neurol. 7 4 2008 299 309 10.1016/S1474-4422(08)70044-9 18296121
7. DeVetten G., Coutts S.B., Hill M.D., Goyal M., Eesa M., O'Brien B., and et al. Acute corticospinal tract Wallerian degeneration is associated with stroke outcome Stroke 41 4 2010 751 756 10.1161/STROKEAHA.109.573287 20203322
8. Ebinger M., Christensen S., De Silva D.A., Parsons M.W., Levi C.R., Butcher K.S., and et al. Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point Stroke 40 4 2009 1353 1358 10.1161/STROKEAHA.108.532622 19246703
9. Eilaghi A., Brooks J., d'Esterre C., Zhang L., Swartz R.H., Lee T.Y., and et al. Reperfusion is a stronger predictor of good clinical outcome than recanalization in ischemic stroke Radiology 269 1 2013 240 248 10.1148/radiol.13122327 23716707
10. Eilaghi A., d'Esterre C.D., Lee T.Y., Jakubovic R., Brooks J., Liu R.T., and et al. Toward patient-tailored perfusion thresholds for prediction of stroke outcome AJNR Am. J. Neuroradiol. 35 3 2014 472 477 10.3174/ajnr.A3740 24113471
11. Furlan A.J., Eyding D., Albers G.W., Al-Rawi Y., Lees K.R., Rowley H.A., and et al. Dose escalation of desmoteplase for acute ischemic stroke (dedas): evidence of safety and efficacy 3 to 9 hours after stroke onset Stroke 37 5 2006 1227 1231 10.1161/01.STR.0000217403.66996.6d 16574922
12. Gaudinski M.R., Henning E.C., Miracle A., Luby M., Warach S., and Latour L.L. Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant Stroke 39 10 2008 2765 2768 10.1161/STROKEAHA.107.512269 18635854
13. Gobbi D.G., Lu Q., Frayne R., and Salluzi M. Cerebra-WML: a rapid workflow for quantification of white matter hyperintensities Canadian Stroke Congress 2012
14. Hacke W., Albers G., Al-Rawi Y., Bogousslavsky J., Davalos A., Eliasziw M., and et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase Stroke 36 1 2005 66 73 10.1161/01.STR.0000149938.08731.2c 15569863
15. Heiss W.D., Kracht L., Grond M., Rudolf J., Bauer B., Wienhard K., and et al. Early [(11)c]Flumazenil/h(2)o positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy Stroke 31 2 2000 366 369 10.1161/01.STR.31.2.366 10657407
16. Hu M.H., Hsu S.S., Yip P.K., Jeng J.S., and Wang Y.H. Early and intensive rehabilitation predicts good functional outcomes in patients admitted to the stroke intensive care unit Disabil. Rehabil. 32 15 2010 1251 1259 10.3109/09638280903464448 20131942
17. Lansberg M.G., Straka M., Kemp S., Mlynash M., Wechsler L.R., Jovin T.G., and et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study Lancet Neurol. 11 10 2012 860 867 10.1016/S1474-4422(12)70203-X 22954705
18. Lauzon M.L., Sevick R.J., Demchuk A.M., and Frayne R. Stroke imaging at 3.0 T Neuroimaging Clin. N. Am. 16 2 2006 343 366 10.1016/j.nic.2006.02.004 16731371
19. Lemmens R., Mlynash M., Straka M., Kemp S., Bammer R., Marks M.P., and et al. Comparison of the response to endovascular reperfusion in relation to site of arterial occlusion Neurology 81 7 2013 614 618 10.1212/WNL.0b013e3182a08f07 23851962
20. Lev M.H., Segal A.Z., Farkas J., Hossain S.T., Putman C., Hunter G.J., and et al. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome Stroke 32 9 2001 2021 2028 10.1161/hs0901.095680 11546891
21. Olivot J.M., Mlynash M., Thijs V.N., Kemp S., Lansberg M.G., Wechsler L., and et al. Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE) Stroke 39 8 2008 2257 2263 10.1161/STROKEAHA.107.511535 18566302
22. Rha J.H., and Saver J.L. The impact of recanalization on ischemic stroke outcome: a meta-analysis Stroke 38 3 2007 967 973 10.1161/01.STR.0000258112.14918.24 17272772
23. Rosenberg G.A. Ischemic brain edema Prog Cardiovasc Dis 42 3 1999 209 216 10.1016/S0033-0620(99)70003-4 10598921
24. Saver J.L., Johnston K.C., Homer D., Wityk R., Koroshetz W., Truskowski L.L., and et al. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS investigators Stroke 30 2 1999 293 298 10.1161/01.STR.30.2.293 9933262
25. Simon J.E., Bristow M.S., Lu H., Lauzon M.L., Brown R.A., Manjón J.V., and et al. A novel method to derive separate gray and white matter cerebral blood flow measures from MR imaging of acute ischemic stroke patients J. Cereb. Blood Flow Metab. 25 9 2005 1236 1243 10.1038/sj.jcbfm.9600130 15889045
26. Tan I.Y., Demchuk A.M., Hopyan J., Zhang L., Gladstone D., Wong K., and et al. CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct AJNR Am. J. Neuroradiol. 30 3 2009 525 531 10.3174/ajnr.A1408 19147716
27. Tourdias T., Renou P., Sibon I., Asselineau J., Bracoud L., Dumoulin M., and et al. Final cerebral infarct volume is predictable by MR imaging at 1 week AJNR Am. J. Neuroradiol. 32 2 2011 352 358 10.3174/ajnr.A2271 20966063
28. Warach S., Kaufman D., Chiu D., Devlin T., Luby M., Rashid A., and et al. Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: the GAIN MRI substudy Cerebrovasc. Dis. 21 1-2 2006 106 111 10.1159/000090208 16340185
29. Warach S., Pettigrew L.C., Dashe J.F., Pullicino P., Lefkowitz D.M., Sabounjian L., and et al. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 investigators Ann. Neurol. 48 5 2000 713 722 11079534
30. Wheeler H.M., Mlynash M., Inoue M., Tipirneni A., Liggins J., Zaharchuk G., and et al. Early diffusion-weighted imaging and perfusion-weighted imaging lesion volumes forecast final infarct size in DEFUSE 2 Stroke 44 3 2013 681 685 10.1161/STROKEAHA.111.000135 23390119